CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
diuretics +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000485
NCT00000485Phase 3Completed

Hypertension Detection and Follow-up Program (HDFP)

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Jul 12, 2016

In Brief

A Phase 3 clinical trial evaluating diuretics and antihypertensive agents for Cardiovascular Diseases and 3 related conditions. Completed.

Detailed Summary

To determine the effectiveness of systematic, sustained, antihypertensive therapy in reducing morbidity and mortality from hypertension in a wide spectrum of persons with elevated blood pressure in 14 communities. During its course, the trial also obtained a direct measure of the prevalence, severity, and treatment status of representative white and black populations with high blood pressure in these 14 communities, and obtained an estimate of the extent of attainable reduction of complications of high blood pressure by an organized screening and blood pressure management program.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
19701971197219731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
First PostedOct 28, 1999
Enrollment StartMay 1, 1971
Study CompletionMay 1, 1982
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

diureticsdrug

antihypertensive agentsdrug